JPWO2020059847A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020059847A5
JPWO2020059847A5 JP2020549113A JP2020549113A JPWO2020059847A5 JP WO2020059847 A5 JPWO2020059847 A5 JP WO2020059847A5 JP 2020549113 A JP2020549113 A JP 2020549113A JP 2020549113 A JP2020549113 A JP 2020549113A JP WO2020059847 A5 JPWO2020059847 A5 JP WO2020059847A5
Authority
JP
Japan
Prior art keywords
amino acid
acid sequence
seq
sequence shown
deleted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020549113A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2020059847A1 (ja
JP7475687B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2019/036926 external-priority patent/WO2020059847A1/ja
Publication of JPWO2020059847A1 publication Critical patent/JPWO2020059847A1/ja
Publication of JPWO2020059847A5 publication Critical patent/JPWO2020059847A5/ja
Application granted granted Critical
Publication of JP7475687B2 publication Critical patent/JP7475687B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020549113A 2018-09-21 2019-09-20 ヒトhmgb1に特異的に結合するヒトモノクローナル抗体、及びそれを含有するアルツハイマー病を治療又は予防するための医薬組成物 Active JP7475687B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018176802 2018-09-21
JP2018176802 2018-09-21
PCT/JP2019/036926 WO2020059847A1 (ja) 2018-09-21 2019-09-20 ヒトhmgb1に特異的に結合するヒトモノクローナル抗体、及びそれを含有するアルツハイマー病を治療又は予防するための医薬組成物

Publications (3)

Publication Number Publication Date
JPWO2020059847A1 JPWO2020059847A1 (ja) 2021-09-16
JPWO2020059847A5 true JPWO2020059847A5 (https=) 2022-08-18
JP7475687B2 JP7475687B2 (ja) 2024-04-30

Family

ID=69887206

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020549113A Active JP7475687B2 (ja) 2018-09-21 2019-09-20 ヒトhmgb1に特異的に結合するヒトモノクローナル抗体、及びそれを含有するアルツハイマー病を治療又は予防するための医薬組成物

Country Status (4)

Country Link
US (1) US12319731B2 (https=)
EP (1) EP3854875B1 (https=)
JP (1) JP7475687B2 (https=)
WO (1) WO2020059847A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111201030B (zh) 2017-07-25 2024-11-01 真和制药有限公司 通过阻断tim-3和其配体的相互作用治疗癌症
WO2020160156A2 (en) 2019-01-30 2020-08-06 Immutics, Inc. Anti-gal3 antibodies and uses thereof
EP4157338A4 (en) 2020-05-26 2024-11-13 TrueBinding, Inc. METHOD FOR TREATING INFLAMMATORY DISEASES BY GALECTIN-3 BLOCKING
US20240025985A1 (en) * 2020-12-09 2024-01-25 National University Corporation Tokyo Medical And Dental University Agent for Preventing or Treating Frontotemporal Lobar Degeneration
JPWO2023238869A1 (https=) 2022-06-07 2023-12-14
EP4669665A2 (en) * 2023-02-24 2025-12-31 Twist Bioscience Corporation MAST CELL VARIANT NUCLEIC ACID LIBRARIES
CN119775408B (zh) * 2025-03-12 2025-05-30 武汉伊莱瑞特生物科技股份有限公司 抗猴高迁移率族蛋白b1单克隆抗体、酶联免疫检测试剂盒及其应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5807715A (en) 1984-08-27 1998-09-15 The Board Of Trustees Of The Leland Stanford Junior University Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
JP2928287B2 (ja) 1988-09-29 1999-08-03 協和醗酵工業株式会社 新規ポリペプチド
US5047335A (en) 1988-12-21 1991-09-10 The Regents Of The University Of Calif. Process for controlling intracellular glycosylation of proteins
IL162181A (en) 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
JPH0322979A (ja) 1989-06-19 1991-01-31 Kyowa Hakko Kogyo Co Ltd 新規プラスミノーゲン活性化因子
US6657103B1 (en) 1990-01-12 2003-12-02 Abgenix, Inc. Human antibodies derived from immunized xenomice
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
ATE158021T1 (de) 1990-08-29 1997-09-15 Genpharm Int Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5278299A (en) 1991-03-18 1994-01-11 Scripps Clinic And Research Foundation Method and composition for synthesizing sialylated glycosyl compounds
WO1993010260A1 (en) 1991-11-21 1993-05-27 The Board Of Trustees Of The Leland Stanford Junior University Controlling degradation of glycoprotein oligosaccharides by extracellular glycosisases
US5648267A (en) 1992-11-13 1997-07-15 Idec Pharmaceuticals Corporation Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising same
CU22615A1 (es) 1994-06-30 2000-02-10 Centro Inmunologia Molecular Procedimiento de obtención de anticuerpos monoclonales murinos menos inmunogénicos. anticuerpos monoclonales obtenidos
DE69535243T2 (de) 1994-07-13 2007-05-10 Chugai Seiyaku K.K. Gegen menschliches interleukin-8 gerichteter, rekonstituierter menschlicher antikörper
DK1071700T3 (da) 1998-04-20 2010-06-07 Glycart Biotechnology Ag Glykosylerings-modifikation af antistoffer til forbedring af antistofafhængig cellulær cytotoksicitet
CA2953239A1 (en) 2000-10-06 2002-04-18 Kyowa Hakko Kirin Co., Ltd. Antibody composition-producing cell
CA2430013C (en) 2000-11-30 2011-11-22 Medarex, Inc. Transgenic transchromosomal rodents for making human antibodies
US8372954B2 (en) 2000-12-22 2013-02-12 National Research Council Of Canada Phage display libraries of human VH fragments
JP4242128B2 (ja) 2002-09-18 2009-03-18 武田薬品工業株式会社 脳アミロイドーシス予防・治療薬のスクリーニング方法
WO2007001422A2 (en) 2004-10-22 2007-01-04 Medimmune, Inc. High affinity antibodies against hmgb1 and methods of use thereof
JP5225109B2 (ja) 2007-02-15 2013-07-03 国立大学法人 熊本大学 ヒトhmgb−1に特異的に結合する抗体を有効成分として含有する治療剤
CA2897914A1 (en) * 2013-01-28 2014-07-31 Evec Inc. Humanized anti-hmgb1 antibody or antigen-binding fragment thereof
WO2018030405A1 (ja) * 2016-08-09 2018-02-15 国立大学法人東京医科歯科大学 Hmgb1に対する抗体、及びそれを含有するアルツハイマー病を治療又は予防するための組成物

Similar Documents

Publication Publication Date Title
JPWO2020059847A5 (https=)
JP7840836B2 (ja) 改善された血清アルブミン結合性免疫グロブリン可変ドメイン
JP2022502371A5 (https=)
JP2024167313A5 (https=)
JP2011509245A5 (https=)
JP2020506898A5 (https=)
JP2022545196A5 (https=)
JP2020537644A5 (https=)
JP2016529229A5 (https=)
RU2019118359A (ru) Антитело к cd73 человека
JP2019515646A5 (https=)
JP2018502050A5 (https=)
JP2010536384A5 (https=)
JP2019527194A5 (https=)
JP2018510617A5 (https=)
JP2019511911A5 (https=)
JP2019505527A5 (https=)
JP2019521647A5 (https=)
JP2010509931A5 (https=)
JP2023505492A5 (https=)
JP2021520393A5 (https=)
JP2018514193A5 (https=)
JP2022505585A5 (https=)
JP2022516071A5 (https=)
JP2017504321A5 (https=)